SG
PAVM icon

StoneX Group’s PAVmed PAVM Stock Holding History

StoneX Group’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-410
Closed -$2.72K – 1168
2025
Q4 		$2.72K Buy
+410
New +$4.68K ﹤0.01% 1063

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

StoneX Group's PAVM Position: Q1 2026 in Review

StoneX Group sold out of PAVmed (PAVM) in Q1 2026, closing a stake of 410 shares — an estimated $2.72K sold.

StoneX Group first reported a position in PAVM in Q4 2025 and held it in 1 quarter. The position peaked at $2.72K in Q4 2025. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • StoneX Group reported no remaining PAVmed position as of Q1 2026 after selling out during the quarter.
  • StoneX Group sold 410 PAVmed shares in Q1 2026, an estimated $2.72K.
  • StoneX Group first reported a position in PAVmed in Q4 2025 and held it in 1 quarter.
  • StoneX Group's PAVmed position peaked at $2.72K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.